Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | APAF1 | O14727 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.64 |
| ▸ | FDPS | P14324 | 17/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL926641 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29397456 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29396405 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29850939 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29874994 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29396755 | 1.00 | MEN1 (0.64) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29450332 | 0.95 | MEN1 (0.55) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL625417 | 0.95 | MEN1 (0.55) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL29395782 | 0.89 | SMN1; SMN2 (0.46) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL31057990 | 0.87 | MEN1 (0.52) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719765-A1 | A BONDED STRUCTURE | Henkel AG & Co. KGaA (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-4540296-A1 | TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2025-04-23 | — | — | EP | claimed |
| WO-2025049220-A1 | ELECTROLYTE COMPRISING IMIDAZOLIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME | FACTORIAL INC. (US) | 2025-03-06 | — | — | WO | claimed |
| WO-2024251456-A1 | A BONDED STRUCTURE | HENKEL AG & CO. KGAA (DE) | 2024-12-12 | — | — | WO | claimed |
| WO-2023241875-A1 | TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2023-12-21 | — | — | WO | claimed |
| CN-117050023-A | Method for preparing 5-fluorocytosine | 浙江省化工研究院有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-114705247-B | Ion type capacitive pressure and temperature sensing fiber device capable of being manufactured in batch and preparation method thereof | 杭州师范大学 | 2023-09-22 | — | — | CN | claimed |
| WO-2023090490-A1 | METHOD FOR SEPARATING N-HEXANE AND 1-HEXENE FROM EACH OTHER BY USING IONIC LIQUID | (주)웨니 | 2023-05-25 | — | — | WO | claimed |
| CN-114085425-B | Beta-crystal-form compound nucleating agent and application thereof | 宁波福天新材料科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-115302906-A | Infrared stealth system compatible with electro-variable emissivity and radiation heat dissipation, and preparation method and application thereof | 郑州航空工业管理学院 | 2022-11-08 | — | — | CN | claimed |
| US-20110013252-A1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (compagnie Generale D'optiqu e (FR) | 2011-01-20 | — | — | US | claimed |
| EP-2275090-A2 | Microparticles prepared using an ionic liquid | Novartis AG (CH) | 2011-01-19 | — | — | EP | claimed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | claimed |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | AUSBORN MICHAEL | 2006-07-06 | — | — | US | claimed |
| US-20050205493-A1 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2005-09-22 | — | — | US | claimed |
| EP-1569621-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | Novartis AG (CH) | 2005-09-07 | — | — | EP | claimed |
| EP-1529205-A2 | ANALYTICAL PROCESS | Novartis AG (CH) | 2005-05-11 | — | — | EP | claimed |
| WO-2004052340-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | claimed |
| WO-2004013612-A2 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | NOVARTIS AG (CH) | 2004-02-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | MEN1 1303/4885HSP90AA1 2183/4885KMT2A 4402/4885 |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | FIBP, MIF, CHMP4B | MEN1 1303/4885HSP90AA1 2183/4885KMT2A 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.